(DIR) Return Create A Forum - Home --------------------------------------------------------- MS Speaks (HTM) https://msspeaks.createaforum.com --------------------------------------------------------- ***************************************************** (DIR) Return to: BRIUMVI (ublituximab) ***************************************************** #Post#: 3335-------------------------------------------------- Ublituximab "reassuring" as potential relapsing MS the rapy By: agate Date: June 30, 2021, 6:47 pm --------------------------------------------------------- From Multiple Sclerosis News Today (June 30, 2021)--"Ublituximab 'Quite Reassuring' as Potential RMS Therapy, Experts Say": (HTM) https://multiplesclerosisnewstoday.com/news-posts/2021/06/30/ublituximab-tg-therpeutics-potential-relapsing-ms-therapy-interview-article/ #Post#: 3424-------------------------------------------------- Ublituximab up for FDA approval By: agate Date: October 2, 2021, 1:04 am --------------------------------------------------------- From Multiple Sclerosis News Today (October 1, 2021)--"Ublituximab, Potential Relapsing MS Therapy, Up for FDA Approval": (HTM) https://multiplesclerosisnewstoday.com/news-posts/2021/10/01/tg-therapeutics-asks-fda-approval-ublituximab-relapsing-ms/ #Post#: 3505-------------------------------------------------- Ublituximab as relapsing MS therapy under FDA review By: agate Date: December 23, 2021, 1:29 am --------------------------------------------------------- More on this, from Multiple Sclerosis News Today (December 15, 2021)--"Ublituximab as relapsing MS therapy under FDA review": (HTM) https://bit.ly/32dLrDm #Post#: 3687-------------------------------------------------- (CMSC) Ubilituximab tied to slowed disease progression in relaps ing MS By: agate Date: June 18, 2022, 1:19 am --------------------------------------------------------- From Medscape Today (June 10, 2022)--"Novel drug tied to slowed disease progression in relapsing MS": (HTM) https://www.medscape.com/viewarticle/975368 #Post#: 3755-------------------------------------------------- (Abst.) Ublituximab vs. teriflunomide in relapsing MS By: agate Date: August 27, 2022, 1:35 am --------------------------------------------------------- From PubMed (August 25, 2022), citing a New England Journal of Medicine article, "Ublituximab versus teriflunomide in relapsing multiple sclerosis": (HTM) https://pubmed.ncbi.nlm.nih.gov/36001711/ #Post#: 3769-------------------------------------------------- New MS drug shows promise in trial By: agate Date: September 9, 2022, 7:14 pm --------------------------------------------------------- From WebMD (August 22, 2022)--"New MS Treatment Shows Promise in Trial": (HTM) https://wb.md/3BwD1pu *****************************************************